A | Lymph node metastasis | ||||||
---|---|---|---|---|---|---|---|
Variable | B | SE | Wald | P | OR | 95% CI for OR | |
Lower limit | Upper limit | ||||||
High-ITGA3/CD9 | 1.063 | 0.203 | 27.545 | 0.000 | 2.896 | 1.947 | 4.307 |
YK41 | 0.961 | 0.216 | 19.887 | 0.000 | 2.614 | 1.714 | 3.989 |
Size2 | 0.622 | 0.186 | 11.126 | 0.001 | 1.862 | 1.292 | 2.684 |
B | Primary site recurrence | ||||||
Variable | B | SE | Wald | P | OR | 95% CI for OR | |
Lower limit | Upper limit | ||||||
High-ITGA3/CD9 | 1.090 | 0.415 | 6.895 | 0.009 | 2.973 | 1.318 | 6.706 |
T3-43 | 0.955 | 0.387 | 6.088 | 0.014 | 2.597 | 1.217 | 5.544 |
Positive margin4 | 1.715 | 0.402 | 18.183 | 0.000 | 5.556 | 2.526 | 12.221 |
C | Distant metastasis | ||||||
Variable | B | SE | Wald | P | OR | 95% CI for OR | |
Lower limit | Upper limit | ||||||
High-ITGB4/JUP | 2.311 | 0.771 | 8.990 | 0.003 | 10.088 | 2.227 | 45.704 |
High-ITGA3/CD9 | 2.108 | 1.047 | 4.051 | 0.044 | 8.233 | 1.057 | 64.135 |
D | Death outcome 5 | ||||||
Variable | B | SE | Wald | P | OR | 95% CI for OR | |
Lower limit | Upper limit | ||||||
High-ITGA3/CD9 | 1.618 | 0.450 | 12.947 | 0.000 | 5.041 | 2.089 | 12.166 |
YK4 | 2.355 | 0.613 | 14.743 | 0.000 | 10.540 | 3.168 | 35.074 |
Positive margin | 1.906 | 0.398 | 22.954 | 0.000 | 6.725 | 3.084 | 14.665 |